Category Archives: HaCaT Cell

Have you ever had challenges with inconsistent in vitro models in the testing of skin therapies or wound agents? Do you experience that primary keratinocytes quickly senesce, vary from donor to donor or become prohibitively expensive?   In the meantime, there is pressure on reproducibility, and translational gaps between the bench and the bedside keep growing.    […]